RecruitingPhase 3NCT07266402
A Study to Investigate Efficacy, Safety and Tolerability of Barzolvolimab Versus Placebo in Adults With Cold Induced Urticaria and Symptomatic Dermographism Inadequately Controlled by H1-antihistamines (EMBARQ - ColdU and SD)
Studying Familial cold urticaria
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Celldex Therapeutics
- Intervention
- Barzolvolimab(drug)
- Enrollment
- 240 target
- Eligibility
- 18 years · All sexes
- Timeline
- 2026 – 2028
Study locations (30)
- Cahaba Dermatology & Skin Health Center, LLC, Birmingham, Alabama, United States
- One of a Kind Clinical Research Center, LLC, Scottsdale, Arizona, United States
- Kern Research, Inc., Bakersfield, California, United States
- One of a Kind Clinical Research Center, Napa, California, United States
- Allergy & Asthma Consultants, Redwood City, California, United States
- Amicis Research Center, Sherman Oaks, California, United States
- FOMAT - Allergy, Asthma & Immunology Medical Group, Ventura, California, United States
- Direct Helpers Research Center, Hialeah, Florida, United States
- Well Pharma Medical Research, Corp., Miami, Florida, United States
- Deluxe Health Center, LLC, Miami Lakes, Florida, United States
- GCP, Global Clinical Professionals, St. Petersburg, Florida, United States
- Advanced Clinical Research Institute, Tampa, Florida, United States
- Centricity Research Columbus Dermatology, Columbus, Georgia, United States
- Treasure Valley Medical Research, Boise, Idaho, United States
- Endeavor Health Clinical Trials Center, Skokie, Illinois, United States
- +15 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT07266402 on ClinicalTrials.govOther trials for Familial cold urticaria
Additional recruiting or active studies for the same condition.